The global influenza diagnostics market is currently valued at around USD 2 billion and is expected to reach USD 3 billion by 2021, says Technavio.
Technavio has announced its latest market research report on the global influenza diagnostics market, under its in-vitro diagnostics portfolio. This market analysis discusses the major drivers and key emerging trends and offers an analysis of key vendors like Toppan Printing Mitsubishi Plastic, Amcor, Bemis, and Berry Plastics.
According to Barath Palada, a lead analyst for in-vitro diagnostics research at Technavio, “The global market for influenza diagnostics is currently experiencing a surge in the demand for fully automated and semi-automated systems over conventional (manual) systems. Automated systems provide precise results, which are otherwise difficult to achieve.”
Vendors are developing devices and systems that help integrate laboratory applications. For instance, the cobas Influenza A/B nucleic acid test is used in the modular platform of Roche Diagnostics’ cobas Liat System, which offers optimum efficiency and consolidation in medium- and high-volume laboratories.
Leasing of influenza diagnostics instruments
Leasing the costly influenza diagnostics instruments is an effective and convenient purchasing alternative for end-users with limited budgets. The approach increases the flexibility and provide tax benefits to improve the business of manufacturers. The business model followed in the leasing of instruments by manufacturers is to lease the instruments to the labs for a year on a contract basis and making mandatory to purchase the reagents from the same company for an entire year. The trend of leasing influenza diagnostics instruments is especially prominent in the APAC region.
Potential opportunities for POL
The overall growth of POL market in next five years is expected to aid the overall average growth of global influenza diagnostics market. The POL market features various in-office tests that have been hugely implemented because of the effective CLIA-waived testing.
This market research report includes an in-depth analysis and market shares and sizes of the sub-segments and geography. An analysis of the key companies, including their market shares, business overview, key financials, etc. is provided in this study. This market study also provides a detailed analysis of key drivers, challenges, and opportunities influencing this market.
A more detailed analysis is available in the Technavio report titled, ‘Global Influenza Diagnostics Market 2017-2021’.
Other related reports:
- Global Genomics Biomarkers Market 2017-2021
- Global HPV Testing Market 2016-2020
- Global Nucleic Acid Testing Market 2016-2020
To read more press releases – click here
